IP Library Granted Patent US 9,295,648
Granted Patent B2
US 9,295,648 · App. 14/075,536 · Granted Mar 29, 2016

Injectable microspheres for dermal augmentation and tissue bulking

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,295,648
App. No.
14/075,536
Granted
Mar 29, 2016
Kind
B2
Abstract

The present invention relates to elastic, hydrophilic and substantially spherical microspheres useful for dermal augmentation and tissue bulking. The invention provides injectable compositions comprising the microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further provides methods of dermal augmentation and tissue bulking, particularly for the treatment of skin contour deficiencies, Gastro-esophageal reflux disease, urinary incontinence, and urinary reflux disease, using the injectable compositions.

Claims (28)

1. A composition for tissue bulking or dermal augmentation, the composition comprising:

bulking agents,

a polysaccharide, and

a biocompatible carrier,

wherein all the bulking agents in the composition are polymeric microspheres that are non-resorbable, hydrophilicm, and non-biodegradable.

2. The composition of claim 1 , wherein the polymeric microspheres are elastic, hydrophilic, cationic, non-toxic and substantially spherical.

3. The composition of claim 1 , wherein the polymeric microspheres comprise at least one of an acrylic polymer, a vinyl alcohol polymer, an acrylamide polymer, an acrylate polymer, or mixtures thereof.

4. The composition of claim 1 , wherein the polymeric microspheres comprise at least one of hydroxymethyl methacrylate, diethylaminoethyl acrylamide, or N,N-methylene-bis-acrylamide.

5. The composition of claim 1 , wherein the polymeric microspheres further comprise gelatin.

6. The composition of claim 1 , wherein the polysaccharide comprises dextran.

7. The composition of claim 1 , wherein the composition further comprises a therapeutic agent, drug, or a mixture thereof.

8. The composition of claim 1 , wherein the polymeric microspheres are not capable of being digested or eliminated by a mammal's lymphatic system.

9. The composition of claim 1 , wherein the diameters of the microspheres range from between about 10 μm to about 2000 μm.

10. An injectable composition suitable for the treatment of urinary incontinence or urinary reflux disease, the composition comprising:

bulking agents,

a polysaccharide, and

a biocompatible carrier,

wherein all the bulking agents in the composition are polymeric microspheres that are non-resorbable, hydrophilic, and non-biodegradable.

11. The injectable composition of claim 10 , wherein the treatment of urinary incontinence or urinary reflux disease comprises injecting the composition of claim 10 through a needle.

12. The injectable composition of claim 10 , wherein the polymeric microspheres are elastic, hydrophilic, cationic, non-toxic and substantially spherical.

13. The injectable composition of claim 10 , wherein the polymeric microspheres comprise at least one of an acrylic polymer, a vinyl alcohol polymer, an acrylamide polymer, an acrylate polymer, or mixtures thereof.

14. The injectable composition of claim 10 , wherein the polymeric microspheres comprise at least one of hydroxymethyl methacrylate, diethylaminoethyl acrylamide, or N,N-methylene-bis-acrylamide.

15. The injectable composition of claim 10 , wherein the polymeric microspheres further comprise gelatin.

16. The injectable composition of claim 10 , wherein the polysaccharide comprises dextran.

17. The injectable composition of claim 10 , wherein the composition further comprises a therapeutic agent, drug, or a mixture thereof.

18. The injectable composition of claim 10 , wherein the composition is a suspension of the polymeric microspheres in the biocompatible carrier.

19. The injectable composition of claim 10 , wherein the polymeric microspheres are not capable of being digested or eliminated by a mammal's lymphatic system.

20. The injectable composition of claim 10 , wherein the diameters of the microspheres range from between about 10 μm to about 2000 μm.

Assignments (2)
SECURITY INTEREST Recorded Jul 26, 2016
From: BIOSPHERE MEDICAL, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 039262/0030 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2013
From: VOGEL, JEAN-MARIE; THOMAS, RICHARD; BOSCHETTI, EGISTO
To: BIOSPHERE MEDICAL, INC.
Reel/Frame 031570/0099 →